Gefapixant Reduces Chronic Cough in Phase III Trials

(MedPage Today) -- Higher doses of the investigational oral drug gefapixant significantly decreased cough frequency compared to placebo in two highly anticipated phase III studies, but well over half of patients in both trials reported taste-related...